Soluble Engineered Monomeric FC Read more about Soluble Engineered Monomeric FC United Kingdom13713301.3Filed on 2013-03-14
Soluble Engineered Monomeric FC Read more about Soluble Engineered Monomeric FC France13713301.3Filed on 2013-03-14
Soluble Engineered Monomeric FC Read more about Soluble Engineered Monomeric FC Germany13713301.3Filed on 2013-03-14
METHODS FOR INDENTIFYING, DIAGNOSING, AND PREDICTING SURVIVAL OF LYMPHOMAS Read more about METHODS FOR INDENTIFYING, DIAGNOSING, AND PREDICTING SURVIVAL OF LYMPHOMAS US Patent 10,697,975Filed on 2017-06-22
IL-15/IL-15 RECEPTOR ALPHA TREATMENT REGIMENS AND USE WITH THERAPEUTIC VACCINES Read more about IL-15/IL-15 RECEPTOR ALPHA TREATMENT REGIMENS AND USE WITH THERAPEUTIC VACCINES Patent Cooperation TreatyPCT/US2017/042002Filed on 2017-07-13
FUROQUINOLINEDIONES AS INHIBITORS OF TDP2 Read more about FUROQUINOLINEDIONES AS INHIBITORS OF TDP2 US Patent 10,906,914Filed on 2017-07-10
Furoquinolinedione As Inhibitors Of TDP2 Read more about Furoquinolinedione As Inhibitors Of TDP2 European Patent16703001.4Filed on 2016-01-08
Furoquinolinedione As Inhibitors Of TDP2 Read more about Furoquinolinedione As Inhibitors Of TDP2 Canada2973484Filed on 2016-01-08
Furoquinolinedione As Inhibitors Of TDP2 Read more about Furoquinolinedione As Inhibitors Of TDP2 Australia2016205137Filed on 2016-01-08
T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage Read more about T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage Australia2017204103Filed on 2017-06-16